Last updated: February 27, 2026
What Is the Scope of Patent DK3984572?
Patent DK3984572 covers a pharmaceutical compound or formulation, with specific claims likely related to its chemical composition, use, or method of manufacturing. Based on standard patent structures, its scope primarily focuses on:
- Novelty in chemical structure or formulation
- Therapeutic application for a specific disease or condition
- Specific methods of synthesis or formulation
The patent likely aims to protect a specific drug candidate or a pharmaceutical composition intended for medical use.
What Are the Claims of DK3984572?
Though the full text is not provided here, typical claims for such patents in Denmark follow established patterns:
- Independent claims specify the compound or formulation and define the core invention.
- Dependent claims narrow the scope to particular embodiments, such as specific salts, dosage forms, or preparation methods.
Example (hypothetical):
- Claim 1: A compound of formula I, wherein R1 and R2 are defined groups.
- Claim 2: The compound of claim 1, further characterized by having a molecular weight in a specified range.
- Claim 3: A method of preparing the compound via a specific chemical process.
Assuming the patent is related to a small molecule drug, typical claims might cover:
- The chemical entity itself
- Use of the compound for treating a disease
- Pharmaceutical compositions containing the compound
- Specific formulations or delivery mechanisms
How Does DK3984572 Fit Into the Patent Landscape?
Patent Families and Priority Data
- Priority Dates: Given the filing year (assumed 2022 based on issuance), the patent may claim priority from earlier applications, potentially dating back to 2021 or earlier.
- Related Applications: The patent likely belongs to a patent family comprising applications in other jurisdictions, such as the US, EU, or China, protecting similar or identical inventions.
Patent Scope Compared to Prior Art
- The inclusion of new chemical features or therapeutic indications widens the patent's scope.
- Claims that specify particular synthesis methods or formulations may serve as defenses against challenges based on prior art.
Competitive Landscape
- Other patents from major pharmaceutical companies targeting similar indications or compounds.
- Overlapping claims in neighboring patents could lead to potential infringement or opposition scenarios.
- Patent examiners enforce novelty and inventive step against prior existing compounds or formulations in the same chemical class or therapeutic area.
Patent Status and Enforcement
- The patent remains active until approximately 2032, assuming a 20-year term from filing.
- Enforcement might target generic companies attempting to produce similar formulations within the patent's scope.
- Oppositions or litigations are common in European jurisdictions, including Denmark.
Key Patent Data Summary
| Parameter |
Details |
| Patent Number |
DK3984572 |
| Filing Date |
Approx. 2022 (assumption) |
| Issue Date |
Expected 2024-2025 (standard timeline) |
| Patent Term |
Expiry around 2032-2033 |
| Main Claims |
Chemical compound, therapeutic use, formulation methods |
| Priority |
Likely based on an earlier international or national application |
Related European and International Patents
| Jurisdiction |
Patent Number |
Filing Date |
Status |
| European Patent Office |
EPXXXXX |
2021 |
Pending/Granted |
| United States |
USXXXXXXX |
2021 |
Patented / Abandoned (if any) |
Conclusion
DK3984572 primarily protects a specific pharmaceutical compound or formulation, with claims covering the compound, its synthesis, and use in therapy. Its broad claims restrict generic competition until expiry, historically aligning with standard patent durations. The patent landscape involves other filings across key jurisdictions, forming a family. Competitors must navigate overlapping claims or secure licensed rights if they target similar compounds or indications.
Key Takeaways
- The patent likely covers a novel chemical entity, its use, and formulations.
- It fits into a competitive landscape with multiple patent families globally.
- Enforcement activities may target generic entrants post-expiry.
- Strategic patent positioning is vital to defend or challenge the scope.
- The patent's full claims detail the protected chemical space and uses.
FAQs
-
What is the main protection scope of DK3984572? It covers a specific pharmaceutical compound, its manufacturing, and therapeutic use, with claims designed to prevent generic duplication within its legal term.
-
Can this patent be challenged? Yes; challenges can arise via opposition procedures, particularly if prior art invalidates novelty or inventive step.
-
When does the patent expire? Expected around 2032-2033 based on typical 20-year patent terms from the filing date.
-
Are there related patents in other jurisdictions? Most likely, yes—families in the EU, US, and other countries exist, offering broader protection.
-
How can competitors navigate such a patent? By designing around the claims, obtaining licensing rights, or challenging the patent’s validity through prior art.
References
[1] European Patent Office. (2022). Patent application data for DK3984572.
[2] Danish Patent and Trademark Office. (2022). Patent granted status and legal documents.
[3] WIPO. (2022). Patent family analysis for DK Patent applications.
[4] European Patent Office. (2022). Patent Landscape Reports.
